GlassScriptPhysician profile
Jacob Stout
NPI 1184111916
$685.07
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $144 · 2020: $121 · 2021: $332 · 2022: $62.43 · 2023: $26.01.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $26.01.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $26.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $174.99 | 2019-2021 | |
| Biohaven Pharmaceuticals, INC. | $155.65 | 2021 | |
| Horizon Therapeutics Plc | $72.43 | 2021 | |
| Livanova USA, INC. | $62.43 | 2022 | |
| Acorda Therapeutics, INC | $54.86 | 2019-2020 | |
| Abbvie INC. | $26.01 | 2023 | Botox |
| Csl Behring | $23.97 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $23.64 | 2021 | |
| Akcea Therapeutics, INC. | $22.09 | 2019 | |
| Catalyst Pharmaceuticals, INC. | $20.73 | 2021 | |
| Sanofi-Aventis U.S. LLC | $19.46 | 2020 | |
| Lilly USA, LLC | $16.59 | 2020 | |
| Upsher-Smith Laboratories LLC | $12.22 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacob Stout listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.